Chinook is a Washington-based biopharmaceutical company that develops and commercializes medicines for the treatment of kidney diseases.
Business Model:
Revenue: $56.9M
Employees: 51-200
Address: 400 Fairview Ave North
City: Seattle
State: WA
Zip: 98109
Country: US
Chinook is a Washington-based biopharmaceutical company that develops and commercializes medicines for the treatment of kidney diseases.
Contact Phone:
+16043431552
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/2/2020
Ticker Symbol:
KDNY
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Post-IPO Equity | $105M | 10/2020 | IPO | - | 8/2019 | Series A | 3 | $65M |
Versant Ventures Samsara BioCapital Apple Tree Partners Versant Ventures |
11/2021 | Post-IPO Equity | $159.6M | 10/2020 | Private Placement | $115M | 8/2020 | Private Placement | 12 | $106M |
Ally Bridge Group Apple Tree Partners Avidity Partners EcoR1 Capital Janus Henderson Investors Northleaf Capital Partners OrbiMed Rock Springs Capital Samsara BioCapital Sphera Global Healthcare Fund Surveyor Capital Versant Ventures OrbiMed Avidity Partners Versant Ventures Apple Tree Partners Ally Bridge Group Samsara BioCapital Rock Springs Capital Northleaf Capital Partners EcoR1 Capital Surveyor Capital |
10/2020 | IPO | - |
---|
Announced Date | Name | Price |
---|---|---|
6/2020 | Aduro BioTech |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|